Speakers and Moderators

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Michael Atkins
Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC

Boris C. Bastian
Departments of Dermatology and Pathology, University of California, San Francisco, California

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Gerardo Botti
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Pier Luigi Canonico
Department of Scienze del Farmaco, University of Piemonte Orientale, Novara, Italy

Lotfi Chouchane
Weill Cornell Medical College, Qatar

Gennaro Ciliberto
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Alistair Cochran
Ronald Reagan UCLA Medical Center, UCLA, California

Michael Davies
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Francesco De Lorenzo
President of European Cancer Patient Coalition, ECPC, and of Italian Federation of Volunteer-based Cancer Organizations, FAVO

Sandra Demaria
New York University Langone Medical Center, New York

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Switzerland

Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts

Paolo Foggi*
Italian Medicines Agency, AIFA

Silvia Formenti
New York University Langone Medical Center, New York

Thomas F. Gajewski
Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois

Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France

Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany

Valerie Guild
AIM at Melanoma, Richmond, California

Claudio Jommi
Department of Scienze del Farmaco, University of Piemonte Orientale, Novara, Italy

Rolf Kiessling
Karolinska Institutet, Stockholm, Sweden

John Kirkwood
Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute, Pennsylvania

Roger Lo
Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California

Paul Lorigan
Institute of Cancer Sciences, University of Manchester, Manchester, UK

Alessandro Lugli
Institute of Pathology, University of Bern, Bern, Switzerland

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Center, Doha, Qatar

Giuseppe Masucci
Karolinska Institutet, Stockholm, Sweden

Teresita Mazzei
Department of Health Sciences, University of Florence, Florence, Italy

Grant McArthur
Peter MacCallum Cancer Centre, Melbourne Area, Australia

Ignacio Melero
CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain

Martin Mihm
Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Nicola Mozzillo
Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Giorgio Parmiani
Division of Medical Oncology and Immunotherapy, University Hospital, Siena

Francesco Pignatti
Oncology, Haematology, Diagnostics - Safety and Efficacy Sector at European Medicines Agency, EMA

Carmine Pinto
President of the Italian Association of Medical Oncology, AIOM

Raj K. Puri
Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research FDA, Bethesda, Maryland

Igor Puzanov
Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee

Paola Queirolo
President of the Italian Melanoma Intergroup, IMI

Pedro Romero
Ludwig Center for Cancer Research, University of Lausanne, Switzerland

Francesco Rossi
President of the Italian Society of Pharmacology, SIF

Bettina Ryll
Melanoma Patient Network Europe

Bastian Schilling
Department of Dermatology, University Hospital Essen, Essen, Germany

Jeff Sosman
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

David Stroncek
Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland

Mario Sznol
Yale Cancer Center, New Haven, Connecticut

Janis M. Taube
Departments of Dermatology and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Alessandro Testori
Director of the Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy

Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Sara Tomei
Sidra Medical and Research Centre, Doha, Qatar

Ena Wang
Sidra Medical and Research Centre, Doha, Qatar

Hassane M. Zarour
University of Pittsburgh Cancer Institute Hillman Cancer Center, Pennsylvania

* To be confirmed

For information please contact info@melanomabridge.org